DHR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $215.61
Capitalización Bursátil (MRQ) $151.55B
P/E (TTM) 38.2
BPA (TTM) $5.64
Ingresos (TTM) $25.11B
Rendimiento div. 0.57%
ROE (TTM) 7.6%
Deuda/Capital (MRQ) 0.5
Rango 52S $161–$243

DHR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Divisiones de acciones 7
Fecha ex-dividendo División Tipo
2 de octubre de 2023 141-for-125 Adelante
5 de julio de 2016 1319-for-1000 Adelante
14 de junio de 2010 2-for-1 Adelante
21 de mayo de 2004 2-for-1 Adelante
1 de junio de 1998 2-for-1 Adelante
23 de enero de 1995 2-for-1 Adelante
9 de septiembre de 1987 2-for-1 Adelante

Acerca de Danaher Corporation Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology (28% of 2024 revenues), which develops products for the development of therapeutics; life sciences (31% of 2024 revenues), which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics (41% of 2024 revenues), which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.

The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

History

Early years

The company's origins go back to DMG, Inc., a Massachusetts real estate investment trust organized in 1969. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. In 1983, the Stephen M. Rales and Mitchell P. Rales invested in the company, which at that time was invested in retirement home developments, they then replaced the existing management in a bitter proxy battle.

In 1984, the company adopted the name Danaher and reincorporated under the Delaware General Corporation Law. The name came from a river in Montana.

In 1985, the Rales brothers offered $400 million in a hostile bid for Scott Fetzer Company but lost out to Berkshire Hathaway.

In June 1986, Danaher acquired Chicago Pneumatic in a hostile takeover, offering $60.8 million for the 32% of the company not already owned. The company had merged in July 1984 with a sister company, the Jacobs Manufacturing Co., and had purchased Matco Tools in April 1981.

In June 1987, Danaher sold Chicago Pneumatic while retaining Jacobs, including its Matco Tools Division. Jacobs' name was changed to Matco Tools Corp. In November 1991, the other divisions within Jacobs were established as separate operating companies. In January 1993, Danaher formed NMTC, Inc., which acquired a substantial portion of the assets of MTC, including the existing distributorship agreements of MTC.

In 1986, Danaher added Qualitrol to its instrumentation unit, including Gilbarco Veeder-Root's underground fuel storage sensors, Dynapar's motion sensors, and pressure measurement and temperature measurement instruments used on the electrical transformer industry.

1990–2000

In 1990, Danaher acquired Easco Hand Tools Inc. Danaher was selected as exclusive supplier of hand tools for Sears. In 1994, Danaher acquired Armstrong Tools, the makers of tool brands Armstrong, Allen, and others.

In 1995, Danaher acquired Hengstler GmbH, a manufacturer of counters, printers, relays, and high-precision rotational sensors. Hengstler was Danaher's first acquisition headquartered outside the United States.

In 1999, the company acquired Hach Company, involved in water and wastewater—and analytics, for $325 million.

2001–2010

In 2000, H. Lawrence Culp Jr. was named CEO of Danaher; he had joined the company in 1990.

Danaher acquired Trojan Technologies, an environmental engineering firm, in 2004.

Danaher also acquired UK-based West Instruments, which provides control and measurement instrumentation and services for the global industrial and process markets.

Danaher announced its agreement to acquire the Gendex division from DENTSPLY International on

December 11, 2003, with the acquisition closing in early 2004, integrating this dental imaging company into Danaher's growing dental portfolio.

PMA, a German manufacturer of control and measurement instrumentation, was acquired in April 2005.

In July 2005, Danaher acquired Leica Microsystems, which manufactures products for applications requiring microscopic imaging, measurement and analysis and offers management systems for biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.

In early 2007, Danaher acquired Vision Systems, which manufactures and markets automated instruments, antibodies and biochemical reagents for biopsy-based detection of cancer and infectious diseases, for $520 million.

In July 2007, Danaher acquired ChemTreat.

In November 2007, Danaher purchased Tektronix for US$2.85 billion.

In 2009, Danaher acquired the Analytical Technologies business unit of MDS, including a 50% interest in AB SCIEX, for US$650 million. In February 2010, Danaher acquired the remaining 50% ownership position in AB SCIEX from Life Technologies for US$450 million.

2011–2020

In 2011, Danaher acquired Beckman Coulter, which was divided into a diagnostics segment and a life sciences segment.

In January 2012, Danaher sold Accu-sort to Datalogic.

In December 2012, Danaher acquired Navman Wireless, a provider of on-demand fleet and asset management technology.

In February 2013, Danaher and Cooper Industries sold their joint venture, Apex Tool Group, to Bain Capital for $1.6 billion.

In September 2014, Danaher acquired Nobel Biocare for $2.2 billion.

Effective March 1, 2015, H. Lawrence Culp Jr. resigned as CEO of Danaher.

In July 2015, Danaher combined its communications unit with NetScout Systems.

In August 2015, Danaher acquired Pall Corporation for $13.8 billion.

In June 2016, Danaher completed the corporate spin-off of Fortive, which included Matco and AMMCO-COATS. In September of the same year, the company announced it would acquire Cepheid for $4 billion including debt.

In October 2016, Danaher acquired Phenomenex for $700 million to expand in life sciences.

In October 2017, Danaher announced the acquisition of scientific informatics company ID Business Solutions Ltd. (IDBS). IDBS became part of Danaher's Life Sciences platform.

In March 2018, Danaher acquired Integrated DNA Technologies for an estimated $1.9 billion.

In July 2018, Danaher announced its intention to spin off its Dental segment into a public company, later named Envista Holdings Corporation. The corporate spin-off was completed in December 2019.

In March 2020, Integrated DNA Technologies, a subsidiary of the company, manufactured components for COVID-19 testing.

In March 2020, Danaher acquired the biopharma business of General Electric, a global provider of technologies and services related to the development, manufacture, and delivery of vaccines, diagnostics, and therapeutics to customers in organizations including academia, biotechnology, and drug manufacturing, for $21.4 billion and was rebranded as Cytiva. The GE deal raised monopoly concerns. The Federal Trade Commission conditionally approved the deal on the grounds that Danaher sold some biotechnology assets. In a second deal, Danaher's biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards businesses were sold to Sartorius AG for approximately $825 million. The Cytiva name is derived from 'cyto' meaning 'cell' in Greek, and 'iva' a Latin suffix meaning 'doing' and 'capable of'.

Effective September 2020, Tom Joyce retired as CEO of the company; he was replaced by Executive Vice President Rainer Blair.

2021–present

In June 2021, Precision Nanosystems was acquired by Cytiva.

In August 2021, Danaher acquired Aldevron, which produces mRNA and proteins used in mRNA vaccines, for $9.6 billion in cash.

In May 2023, Pall Corporation merged with Cytiva to create a new Biotechnology Group within Danaher; at that time Cytiva employed more than 16,000 associates in over 40 countries.

Also in September 2022, Danaher announced its intention to spin off its Environmental & Applied Solutions segment; in February 2023, it was named Veralto and the corporate spin-off was completed in September 2023. The division included Aquatic Informatics, ChemTreat, Esko, Hach Company, Linx, McCrometer, OTT HydroMet, Pantone, Sea-Bird Scientific, Trojan Technologies, Videojet, XOS, and X-Rite.

In December 2023, Danaher acquired Abcam for approximately $5.7 billion.

In June 2024, the Food and Drug Administration granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. Using a blood sample from a fingertip, the rapid test detects the virus's RNA and delivers results in less than roughly an hour, as opposed to requiring a sample to be sent to a lab.

In August 2024, the company acquired GeneData. In February 2026, Danaher announced it would acquire Masimo for $10 billion.

Divisions

Life sciences

Abcam

Beckman Coulter - Life Sciences

Cytiva

Integrated DNA Technologies

Leica Microsystems

Molecular Devices

Pall Corporation

SCIEX

Diagnostics

Beckman Coulter - Diagnostics

Cepheid

Leica Biosystems

Radiometer

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealthcare industriaLife Sciences Tools & Services empleados58 000 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$24.57B
2016-12-31 → 2025-12-31
BPA$5.05
2016-12-31 → 2025-12-31
Flujo de caja libre$5.26B
2016-12-31 → 2025-12-31
Margen neto15.9%
2016-12-31 → 2025-12-31
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años DHR promedio 5A Mediana de Pares Veredicto
P/E (TTM) 38.2promedio 5A ≈36.6 ≈36.6 32.0 Sobrevalorado
P/S (TTM) 6.0promedio 5A ≈7.1 ≈7.1 5.4 Valor razonable
P/C (MRQ) 2.9promedio 5A ≈3.5 ≈3.5 6.9 Infravalorado
Precio / FCF (TTM) 27.7promedio 5A ≈28.9 ≈28.9 · ·
Precio / Flujo de Caja (TTM) 22.8promedio 5A ≈23.8 ≈23.8 25.7 Valor razonable
Precio / Valor Contable Tangible (MRQ) 4.9 · · ·
PEG Ratio (Ratio PEG) ≈58.8 · · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Dividendos Rendimiento, ratio de pago, historial de dividendos, CAGR a 5 años

13
Rendimiento por Dividendo0.57%
Ratio de Pago24.3%
Pago anualizado≈$1.60Pago trimestral
CAGR de Dividendos a 5 años≈14.9%Por acción, ajustado por splits
Racha de Crecimiento≈12Años consecutivos de crecimiento de dividendos
Fecha ex-dividendoMontoMonedaRendimiento
Sep 30, 2026$0,40USD≈0.69%
Jun 26, 2026$0,40USD≈0.73%
Mar 27, 2026$0,40USD≈0.75%
Dic 26, 2025$0,32USD≈0.56%
Sep 26, 2025$0,32USD≈0.67%
Jun 27, 2025$0,32USD≈0.59%
Mar 28, 2025$0,32USD≈0.55%
Dic 27, 2024$0,27USD≈0.47%
Sep 27, 2024$0,27USD≈0.38%
Jun 28, 2024$0,27USD≈0.42%
Mar 27, 2024$0,27USD≈0.41%
Dic 28, 2023$0,24USD≈0.42%
Oct 11, 2023$0,27USD≈0.45%
Jun 29, 2023$0,24USD≈0.44%
Mar 30, 2023$0,24USD≈0.41%
Dic 29, 2022$0,22USD≈0.37%
Sep 29, 2022$0,22USD≈0.37%
Jun 23, 2022$0,22USD≈0.36%
Mar 24, 2022$0,22USD≈0.31%
Dic 29, 2021$0,19USD≈0.26%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media 7.2%
Próximo informe Oct 19, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Jul 20, 2026 $1.94 $1.85 4.7%
31 de marzo de 2026 $2.06 $1.96 5.3%
31 de diciembre de 2025 $2.23 $2.17 2.6%
30 de septiembre de 2025 $1.89 $1.74 8.7%
30 de junio de 2025 $1.80 $1.66 8.4%
31 de marzo de 2025 $1.88 $1.66 13.3%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 17
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue $24.57B$23.88B$23.89B$26.64B$24.80B$22.28B$17.91B$17.05B$15.52B$16.88B$14.43B$12.87B
Cost of Revenue $10.04B$9.67B$9.86B$10.46B$9.56B$9.81B$7.93B$7.54B$6.95B$7.55B$6.66B$6.02B
Gross Profit $14.52B$14.21B$14.03B$16.19B$15.24B$12.47B$9.98B$9.51B$8.57B$9.33B$7.77B$6.85B
R&D Expense $1.60B$1.58B$1.50B$1.53B$1.50B$1.35B$1.13B$1.06B$956M$975M$861M$769M
SG&A Expense $8.23B$7.76B$7.33B$7.12B$6.82B$6.90B$5.59B$5.39B$5.04B$5.62B$4.75B$4.04B
Operating Income $4.69B$4.86B$5.20B$7.54B$6.38B$4.23B$3.27B$3.06B$2.57B$2.74B$2.16B$2.04B
Interest Expense ··$286M$204M$231M$275M$108M$137M$140M$184M$140M$95M
Interest Income $30M$117M$303M$41M$11M$71M$139M$9M$8M$200.0K$5M$13M
Other Non-op $-222M$-56M$-175M$-227M$450M$494M$12M$35M····
Pretax Income $4.23B$4.65B$5.04B$7.15B$6.51B$4.50B$3.31B$2.96B$2.54B$2.61B$2.04B$2.09B
Income Tax $633M$747M$823M$818M$1.06B$849M$873M$556M$371M$458M$293M$448M
Net Income $3.61B$3.90B$4.76B$7.21B$6.43B$3.65B$3.01B$2.65B$2.49B$2.55B$3.36B$2.60B
EPS (Basic) $5.07$5.33$6.44$9.80$8.77$4.97$4.11$3.78$3.58$3.69$4.81$3.70
EPS (Diluted) $5.05$5.29$6.38$9.66$8.61$4.89$4.05$3.74$3.53$3.65$4.74$3.63
Shares (Basic) 712,700,000731,000,000736,500,000725,100,000714,600,000706,200,000715,000,000700,600,000695,800,000691,200,000698,100,000702,200,000
Shares (Diluted) 716,100,000737,200,000743,100,000737,100,000736,800,000718,700,000725,500,000710,200,000706,100,000699,800,000708,500,000716,100,000
EBITDA $4.69B$4.86B$7.37B$10.91B$9.63B$6.01B$4.46B$4.71B$4.26B$3.88B$4.52B$4.37B
Balance general 26
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents ······$19.91B$788M$630M$964M$791M$3.01B
Receivables $3.91B$3.54B$3.92B$4.10B$4.63B$4.04B$3.19B$3.03B$3.52B$3.19B$2.99B$3.45B
Inventory $2.49B$2.33B$2.59B$2.77B$2.77B$2.29B$1.63B$1.63B$1.84B$1.71B$1.57B$1.78B
Prepaid Expense $1.74B$1.55B$1.56B$1.74B$1.66B$1.43B$865M$858M$857M$806M$890M$953M
Current Assets $12.76B$9.50B$13.94B$15.88B$11.65B$13.80B$25.60B$7.09B$6.85B$6.67B$7.84B$9.43B
PP&E (Net) $5.53B$4.99B$4.55B$3.71B$3.53B$3.26B$2.30B$2.25B$2.22B$2.35B$2.30B$1.67B
PP&E (Gross) $10.30B$9.09B$8.38B$7.14B$7.25B$6.44B$5.06B$4.70B$4.97B$4.32B$3.99B$4.71B
Accum. Depreciation $4.77B$4.10B$3.83B$3.43B$3.46B$3.18B$2.76B$2.45B$2.52B$1.96B$1.69B$2.54B
Goodwill $43.15B$40.50B$41.61B$37.28B$38.68B$35.42B$22.71B$22.58B$21.77B$23.83B$21.01B$11.58B
Intangibles $17.82B$18.57B$20.75B$19.82B$22.84B$21.28B$9.75B$10.28B$11.67B$11.82B$10.55B$7.06B
Other Non-current Assets $4.21B$3.99B$3.64B$4.16B$3.72B$2.40B$1.72B$571M$538M$631M$845M$1.02B
Total Assets $83.46B$77.54B$84.49B$84.35B$83.18B$76.16B$62.08B$47.83B$46.65B$45.30B$48.22B$36.99B
Accrued Liabilities $4.96B$4.54B$4.81B$4.82B$5.56B$5.34B$3.21B$2.69B$3.09B$2.79B$2.61B$3.19B
Short-term Debt ···········$765M
Current Liabilities $6.81B$6.80B$8.27B$8.39B$8.14B$7.40B$4.93B$4.84B$4.79B$6.87B$6.17B$5.40B
Capital Leases $1.08B$968M$954M$772M$889M$785M$639M$0····
Other Non-current Liabilities $5.70B$5.69B$6.02B$6.50B$7.70B$7.79B$5.35B$4.70B$5.16B$5.67B$5.75B$4.58B
Long-term Debt $18.42B$16.00B$18.40B$19.68B$22.18B$21.20B$21.73B$9.74B$10.52B$12.27B$12.87B$3.47B
Total Debt $18.42B$15.50B$16.71B$19.09B$22.17B$21.19B$21.52B$9.69B$10.33B$9.67B$12.03B$4.17B
Common Stock $9M$9M$9M$9M$9M$9M$8M$8M$8M$8M$8M$8M
Retained Earnings $46.89B$44.19B$41.07B$39.20B$32.83B$27.16B$24.17B$25.16B$22.81B$20.70B$21.01B$20.32B
Treasury Stock $11.35B$8.16B$2.02B·········
AOCI $-207M$-3.22B$-1.75B$-2.87B$-1.03B$-368M$-3.07B$-2.79B$-2.15B$-3.02B$-2.31B$-1.43B
Stockholders' Equity $52.53B$49.54B$53.49B$50.08B$45.17B$39.77B$30.27B$28.21B$26.36B$23.00B$23.69B$23.38B
Liabilities + Equity $83.46B$77.54B$84.49B$84.35B$83.18B$76.16B$62.08B$47.83B$46.65B$45.30B$48.22B$36.99B
Shares Outstanding 706,900,000719,100,000739,200,000728,300,000715,000,000711,000,000695,500,000701,500,000696,600,000692,200,000686,800,000704,300,000
Flujo de Efectivo 19
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A ··$2.17B$2.13B$2.06B$1.77B$1.19B$1.18B$1.12B$1.13B$881M$718M
Stock-based Comp $298M$288M$306M$295M$184M$187M$159M$138M$127M$130M$104M$85M
Amort. of Intangibles $1.70B$1.63B$1.49B$1.43B$1.39B$1.14B$625M$616M$579M$583M$397M$269M
Restructuring ·······$70M$159M$152M$98M$102M
Other Non-cash ··$-72M$-1.25B$-461M$600M$-405M$-88M$-392M$-290M$-746M$100M
Operating Cash Flow $6.42B$6.69B$7.16B$8.52B$8.36B$6.21B$3.95B$4.02B$3.48B$3.52B$3.80B$3.76B
CapEx $1.16B$1.39B$1.38B$1.12B$1.24B$791M$636M$584M$571M$590M$513M$465M
Investing Cash Flow $-1.20B$-1.98B$-7.08B$-2.23B$-12.99B$-21.24B$-1.24B$-2.95B$-843M$-5.24B$-14.95B$-3.44B
Debt Issued ······$12.11B$0$1.78B$3.24B$5.68B$0
Net Debt Issued ······$10.55B$-508M$1.11B$760M$5.65B$-415M
Stock Issued ···$0$0$1.73B$1.44B$0$0$164M$249M$133M
Stock Repurchased $3.09B$5.98B$0$0·······$0
Net Stock Activity $-3.09B$-5.98B·$0$0$1.73B$1.44B$96M$69M$164M$249M$133M
Dividends Paid $878M$768M$821M$818M$742M$615M$527M$433M$378M$400M$354M$228M
Financing Cash Flow $-2.96B$-8.38B$-273M$-2.57B$1.29B$1.01B$16.36B$-797M$-3.10B$2.04B$9.05B$-218M
Net Change in Cash $2.54B$-3.79B$-131M$3.41B$-3.45B$-13.88B$19.12B$158M$-333M$173M$-2.21B$-110M
Taxes Paid $1.20B$1.30B$1.80B$1.80B$1.70B·······
Free Cash Flow $5.26B$5.30B$5.78B$7.37B$7.06B$5.42B$3.32B$3.37B$2.86B$2.93B$3.17B$3.16B
Levered FCF ··$5.54B$7.18B$6.87B$5.19B$3.24B$3.24B$2.72B$2.78B$3.04B$3.07B
Rentabilidad 8
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin 59.1%59.5%58.7%60.2%61.0%56.0%55.7%55.8%55.6%55.3%52.3%52.4%
Operating Margin 19.1%20.4%21.8%27.6%25.4%19.0%18.2%17.1%16.5%16.3%16.9%17.2%
Net Margin 14.7%16.3%19.9%22.9%21.8%16.4%16.8%13.3%13.6%15.1%16.3%13.1%
Pretax Margin 17.2%19.5%21.1%26.4%25.8%20.2%18.4%16.6%16.0%15.5%16.2%17.5%
EBITDA Margin 19.1%20.4%30.8%34.7%32.7%27.0%24.9%23.7%23.2%23.0%22.0%21.9%
ROA 4.5%4.8%5.6%8.6%8.1%5.3%5.5%5.6%5.4%5.5%7.9%7.2%
ROE 7.1%7.6%9.2%15.1%15.2%10.4%10.3%9.7%10.1%10.9%14.3%11.4%
ROIC 5.6%6.3%6.2%10.9%9.3%5.6%4.7%7.2%6.9%6.9%7.6%9.3%
Liquidez y Solvencia 5
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 1.91.41.71.91.41.95.21.51.41.01.31.7
Quick Ratio 0.60.50.50.60.60.54.70.90.90.60.81.2
Debt / Equity 0.40.30.30.40.50.50.70.30.40.40.50.2
LT Debt / Equity 0.40.30.30.40.50.50.70.30.40.40.50.1
Interest Coverage ··18.241.231.415.430.121.618.614.921.328.0
Eficiencia 3
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 0.30.30.30.40.40.30.30.40.40.40.50.6
Inventory Turnover 4.23.93.74.34.55.04.94.74.64.65.15.2
Receivables Turnover 6.66.46.06.66.86.25.85.75.55.55.65.6
Por Acción 5
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share $74.32$68.90$72.36$68.77$63.17$55.93$43.52$40.22$37.84$33.23$34.49$33.19
Revenue / Share $34.31$32.39$32.15$42.70$39.97$31.01$24.69$28.01$25.96$24.12$29.02$27.81
Cash Flow / Share $8.96$9.07$9.64$11.56$11.34$8.64$5.45$5.66$4.93$5.03$5.37$5.25
Cash / Share ······$28.63$1.12$0.90$1.39$1.15$4.27
EPS (TTM) $5.05$5.29$6.38$9.66$8.61$4.89$4.05$3.74$3.53$3.65$4.74$3.63
Tasas de Crecimiento 10
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 2.9%-0.06%-10.3%7.4%11.3%·······
Revenue CAGR 3Y -2.7%-1.3%2.4%·········
Revenue CAGR 5Y 2.0%···········
EPS YoY -4.5%-17.1%-34.0%12.2%76.1%·······
EPS CAGR 3Y -19.4%-15.0%9.3%·········
EPS CAGR 5Y 0.65%···········
Net Income YoY -7.3%-18.2%-33.9%12.1%76.4%·······
Net Income CAGR 3Y -20.6%-15.4%9.3%·········
Net Income CAGR 5Y -0.18%···········
Dividends Paid CAGR 5Y 7.4%···········
Valoración (TTM) 16
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM $24.57B$23.88B$23.89B$26.64B$24.80B$22.28B$17.91B$17.05B$15.52B$16.88B$14.43B$12.87B
Net Income TTM $3.61B$3.90B$4.76B$7.21B$6.43B$3.65B$3.01B$2.65B$2.49B$2.55B$3.36B$2.60B
Market Cap $161.82B$165.07B$171.01B$171.37B$208.55B$140.02B$94.63B$64.13B$57.32B$47.77B$56.55B$53.52B
Enterprise Value ······$96.24B$73.03B$67.02B$56.48B$67.79B$54.68B
P/E 45.343.436.324.433.940.333.624.423.318.917.420.9
P/S 6.66.97.26.48.46.35.33.83.72.83.94.2
P/B 3.13.33.23.44.63.53.12.32.22.12.42.3
P / Cash Flow 25.224.723.920.125.022.623.915.916.513.614.914.2
P / FCF 30.831.229.623.329.525.828.519.120.116.317.816.9
EV / EBITDA ······21.615.515.714.615.012.5
EV / FCF ······29.021.723.419.321.417.3
EV / Revenue ······5.44.34.33.34.74.2
Dividend Yield 0.54%0.47%0.48%0.48%0.36%0.44%0.56%0.68%0.66%0.84%0.63%0.43%
Earnings Yield 2.2%2.3%2.8%4.1%2.9%2.5%3.0%4.1%4.3%5.3%5.8%4.8%
Payout Ratio 24.3%19.7%17.2%11.3%11.5%16.9%17.5%16.4%15.2%15.7%10.5%8.8%
Annual Payout $878M$768M$821M$818M$742M$615M$527M$433M$378M$400M$354M$228M

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $24.57B $23.88B $23.89B $26.64B $24.80B
Margen Bruto % 59.1% 59.5% 58.7% 60.2% 61.0%
Margen Operativo % 19.1% 20.4% 21.8% 27.6% 25.4%
Beneficio neto $3.61B $3.90B $4.76B $7.21B $6.43B
EPS Diluido $5.05 $5.29 $6.38 $9.66 $8.61

Propietarios institucionales (13F) 2 312 declarantes · $121.1B total · A fecha de 30 de septiembre de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 2 312
Valor en tenencia $121.1B
Nuevas posiciones 148
Posiciones cerradas 182
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
148 (-60 vs trimestre anterior) 182 (-73 vs trimestre anterior) 694 (-87 vs trimestre anterior) 1 024 (+88 vs trimestre anterior) -368K

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VANGUARD GROUP INC $13 959 166 172 60 978 360 11,52% Acciones
BlackRock, Inc. $10 492 520 322 55 084 630 8,66% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $7 881 505 437 41 377 076 6,51% Acciones
FMR LLC $5 626 949 757 29 540 895 4,65% Acciones
STATE STREET CORP $5 431 565 288 28 456 019 4,48% Acciones
WELLINGTON MANAGEMENT GROUP LLP $3 108 030 541 16 316 834 2,57% Acciones
Capital International Investors $2 953 960 497 15 504 420 2,44% Acciones
GEODE CAPITAL MANAGEMENT, LLC $2 707 246 740 14 280 335 2,23% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $2 705 808 973 14 205 213 2,23% Acciones
JPMORGAN CHASE & CO $2 349 101 825 12 185 400 1,94% Acciones
MORGAN STANLEY $2 161 750 127 11 348 958 1,78% Acciones
Capital Research Global Investors $2 060 650 455 10 818 030 1,70% Acciones
NORGES BANK $1 816 780 335 9 537 906 1,50% Acciones
EAGLE CAPITAL MANAGEMENT LLC $1 783 176 557 9 361 490 1,47% Acciones
NORTHERN TRUST CORP $1 319 158 000 6 925 441 1,09% Acciones
GENERATION INVESTMENT MANAGEMENT LLP $1 287 948 806 6 761 596 1,06% Acciones
JANUS HENDERSON GROUP PLC $1 222 064 214 6 489 965 1,01% Acciones
GOLDMAN SACHS GROUP INC $1 021 898 650 5 364 861 0,84% Acciones
Nuveen, LLC $998 625 469 5 242 679 0,82% Acciones
BANK OF AMERICA CORP /DE/ $993 845 921 5 217 586 0,82% Acciones
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $990 823 246 5 225 861 0,82% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $983 459 478 5 163 059 0,81% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $979 232 536 5 140 868 0,81% Acciones
Fisher Asset Management, LLC $854 260 080 4 484 774 0,71% Acciones
Legal & General Group Plc $801 056 220 4 205 461 0,66% Acciones
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $762 216 330 3 878 641 0,63% Acciones
Invesco Ltd. $753 537 418 3 955 992 0,62% Acciones
FLOSSBACH VON STORCH SE $747 259 707 3 923 035 0,62% Acciones
Bank of New York Mellon Corp $712 874 853 3 742 518 0,59% Acciones
FRANKLIN RESOURCES INC $702 374 137 3 687 390 0,58% Acciones
PARNASSUS INVESTMENTS, LLC $699 862 950 3 674 207 0,58% Acciones
Holocene Advisors, LP $684 356 163 3 592 798 0,56% Acciones
VANGUARD FIDUCIARY TRUST CO $674 795 972 3 542 608 0,56% Acciones
UBS Group AG $617 826 451 3 243 524 0,51% Acciones
Amundi $549 255 875 2 883 536 0,45% Acciones
PRINCIPAL FINANCIAL GROUP INC $507 487 046 2 664 239 0,42% Acciones
DIMENSIONAL FUND ADVISORS LP $505 131 601 2 651 651 0,42% Acciones
AQR CAPITAL MANAGEMENT LLC $503 199 762 2 641 746 0,42% Acciones
BROWN ADVISORY INC $500 677 350 2 628 487 0,41% Acciones
ROYAL BANK OF CANADA $455 982 000 2 393 859 0,38% Acciones
DEUTSCHE BANK AG\ $446 265 498 2 342 847 0,37% Acciones
AMERIPRISE FINANCIAL INC $444 130 104 2 331 466 0,37% Acciones
FIL Ltd $442 569 613 2 323 444 0,37% Acciones
D1 Capital Partners L.P. $434 682 789 2 282 039 0,36% Acciones
FIRST MANHATTAN CO. LLC. $429 106 102 2 248 424 0,35% Acciones
MANUFACTURERS LIFE INSURANCE COMPANY, THE $410 455 346 2 154 842 0,34% Acciones
MILLENNIUM MANAGEMENT LLC $407 739 012 2 140 587 0,34% Acciones
Castle Hook Partners LP $404 836 478 2 125 349 0,33% Acciones
CIBC Private Wealth Group LLC $402 413 634 2 029 727 0,33% Acciones
WELLS FARGO & COMPANY/MN $401 433 291 2 107 482 0,33% Acciones

Mostrar todos los 2 312 propietarios institucionales →

Activistas y propietarios del %+ 5 9 tenencias

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Mitchell P. Rales ×9 presentaciones 2 de noviembre de 2021 · Presentación inicial · SEC
Steven M. Rales ×6 presentaciones 14 de junio de 2021 · Presentación inicial · SEC
Persona informante no revelada 22 de octubre de 2014 · Presentación inicial M&A / venta SEC
Danaher Corporation., Aegean Acquisition Corp. ×2 presentaciones 9 de diciembre de 2010 · Presentación inicial · SEC
Danaher Corporation, DH Holdings Corp., DH Technologies Development Pte. Ltd. ×3 presentaciones 5 de febrero de 2010 · Presentación inicial · SEC
Equity Group Holdings LLC, Equity Group Holdings II LLC, Steven M. Rales, Mitchell P. Rales ×6 presentaciones 30 de marzo de 2007 · Presentación inicial · SEC
Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada 23 de abril de 2003 · Presentación inicial · SEC
Persona informante no revelada, Persona informante no revelada 8 de junio de 2001 · Presentación inicial · SEC
Persona informante no revelada 25 de mayo de 2001 · Presentación inicial M&A / venta SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 50 insiders · 24 directivos · 12 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Rainer Blair President & CEO 21 de agosto de 2026 S 0 0 3 $-12 736 069
Thomas Patrick Joyce JR President and CEO 24 de julio de 2020 M 203 513 0 0 $0
Lawrence H Culp JR President and CEO 18 de julio de 2014 M 512 199 0 0 $0
Georgeann Couchara SVP, Human Resources 15 de mayo de 2026 F 8 291 0 2 $-1 088 686
Matthew Mcgrew Executive Vice President 1 de marzo de 2026 A 26 825 0 1 $-3 470 835
Bradley R Gray SVP Strategic Development 1 de marzo de 2026 A 14 463 0 0 $0
Brian W Ellis Senior Vice President 4 de febrero de 2026 A 14 994 0 2 $-4 773 810
Daniel Raskas SVP - Corporate Development 1 de febrero de 2025 A 10 524 0 0 $0
William King SVP, Strategic Development 15 de mayo de 2024 M 48 190 0 0 $0
Joakim Weidemanis Executive Vice President 15 de mayo de 2024 F 87 333 0 0 $0
Jennifer Honeycutt Executive Vice President 15 de mayo de 2023 F 26 165 0 0 $0
Angela S Lalor SVP, Human Resources 24 de febrero de 2022 A 47 962 0 0 $0
Robert S Lutz SVP-Chief Accounting Officer 13 de agosto de 2021 M 16 155 0 0 $0
William K Daniel EVP 20 de febrero de 2020 A 109 886 0 0 $0
James A Lico Executive Vice President 10 de mayo de 2016 A 113 198 0 0 $0
Mark A Beck Executive Vice President 28 de julio de 2015 S 0 0 0 $0
Jonathan P Graham Senior VP & GC 19 de mayo de 2015 M 34 606 0 0 $0
James H Ditkoff Senior VP-Finance & Tax 21 de febrero de 2015 F 174 406 0 0 $0
Philip Knisely Executive Vice President 29 de enero de 2010 A 5 010 0 0 $0
Steve Simms Executive Vice President 26 de octubre de 2007 A 4 400 0 0 $0
Patrick W Allender Executive VP 1 de febrero de 2007 M 75 813 0 0 $0
Daniel A Pryor VP-Strategic Development 4 de mayo de 2005 A 0 0 0 $0
Donald E Doles VP-Danaher Business System 31 de agosto de 2004 A · 0 0 $0
Chris Mcmahon VP -- Controller 1 de enero de 2004 A 0 0 0 $0
Charles W Lamanna Consejero 15 de mayo de 2026 A 1 359 0 0 $0
John T Schwieters Consejero 15 de julio de 2025 M 19 815 0 0 $0
Jessica L Mega Consejero 15 de mayo de 2025 A 3 302 0 0 $0
Pardis C Sabeti Consejero 25 de octubre de 2024 A 5 283 0 0 $0
Walter G Lohr Consejero 15 de febrero de 2024 M 14 129 0 0 $0
Donald J Ehrlich Consejero 10 de febrero de 2020 M 123 203 0 0 $0
Robert J Hugin Consejero 15 de mayo de 2017 A 3 576 0 0 $0
Mortimer M Caplin Consejero 26 de abril de 2013 A 83 213 0 0 $0
Emmet A Stephenson JR Consejero 30 de noviembre de 2007 M 368 240 0 0 $0
Matthew E Gugino · 4 de agosto de 2026 A 11 401 0 0 $0
Gregory M Milosevich · 4 de agosto de 2026 A 24 467 0 1 $-274 573
Montgomery Julie A Sawyer · 4 de agosto de 2026 A 22 221 0 0 $0
Christopher Paul Riley · 4 de agosto de 2026 A 61 472 0 0 $0
Christopher Bouda · 4 de agosto de 2026 A 9 107 0 0 $0
Jose-Carlos Gutierrez-Ramos · 4 de agosto de 2026 A 32 495 0 0 $0
Jonathan Leiken · 4 de agosto de 2026 A 12 546 0 0 $0
Mitchell P. Rales · 4 de agosto de 2026 A 553 228 0 9 $-234 561 260
Steven M Rales · 4 de agosto de 2026 A 3 605 808 0 0 $0
Shane A Sanders · 31 de julio de 2026 A 5 914 0 0 $0
Raymond C Stevens · 31 de julio de 2026 A 13 728 0 0 $0
Teri List-Stoll · 31 de julio de 2026 A 21 470 0 1 $-746 997
Feroz Dewan · 31 de julio de 2026 A 4 686 0 0 $0
Elias A. Zerhouni · 31 de julio de 2026 A 45 303 0 0 $0
Linda P Hefner · 31 de julio de 2026 A 26 829 0 0 $0
Alan G Spoon · 31 de julio de 2026 A 124 774 0 1 $-237 202
Daniel L Comas · 23 de octubre de 2020 M 92 683 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 125 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
JXX · Janus Detroit Street Trust 4,03% 5 508 NS 31 de julio de 2026 N-PORT
EQTY · Valued Advisers Trust 3,22% 235 300 NS 31 de julio de 2026 N-PORT
ASLV · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 2,62% 29 365 NS 31 de julio de 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 2,16% 1 006 NS 31 de julio de 2026 N-PORT
IYH · iShares Trust 2,04% 369 897 SH 11 de septiembre de 2026 Diario
GRW · TCW ETF Trust 1,92% 6 380 NS 31 de julio de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,80% 302 986 NS 31 de julio de 2026 N-PORT
VHT · VANGUARD WORLD FUND 1,79% 1 914 802 SH 19 de agosto de 2026 Diario
RSPH · Invesco Exchange-Traded Fund Trust 1,73% 70 526 SH 5 de octubre de 2026 Diario
MEDI · Harbor ETF Trust 1,73% 3 647 NS 31 de julio de 2026 N-PORT
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,67% 5 923 NS 31 de julio de 2026 N-PORT
IXJ · iShares Trust 1,60% 331 014 SH 11 de septiembre de 2026 Diario
CURE · Direxion Shares ETF Trust 1,41% 12 395 NS 31 de julio de 2026 N-PORT
NULV · Nushares ETF Trust 1,30% 147 190 NS 31 de julio de 2026 N-PORT
NULC · Nushares ETF Trust 1,15% 4 154 NS 31 de julio de 2026 N-PORT
PEXL · Pacer Funds Trust 1,13% 2 932 NS 31 de julio de 2026 N-PORT
AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… 1,10% 6 377 NS 31 de julio de 2026 N-PORT
TGLB · T. Rowe Price Exchange-Traded Funds… 1,07% 1 437 NS 31 de julio de 2026 N-PORT
EQWL · Invesco Exchange-Traded Fund Trust 1,06% 137 672 SH 5 de octubre de 2026 Diario
BKDV · BNY Mellon ETF Trust II 1,03% 96 880 NS 31 de julio de 2026 N-PORT
WINN · Harbor ETF Trust 0,81% 46 812 NS 31 de julio de 2026 N-PORT
BIGY · Tidal Trust II 0,79% 2 199 NS 31 de julio de 2026 N-PORT
XT · iShares Trust 0,72% 138 670 SH 11 de septiembre de 2026 Diario
FFLC · FIDELITY COVINGTON TRUST 0,59% 36 489 NS 31 de julio de 2026 N-PORT
IIGD · Invesco Exchange-Traded Self-Indexe… 0,58% 165 000 5 de octubre de 2026 Diario
MGV · VANGUARD WORLD FUND 0,57% 400 375 SH 19 de agosto de 2026 Diario
PFM · Invesco Exchange-Traded Fund Trust 0,55% 20 005 SH 5 de octubre de 2026 Diario
VIG · VANGUARD SPECIALIZED FUNDS 0,52% 3 558 711 SH 19 de agosto de 2026 Diario
USXF · iShares Trust 0,51% 37 795 SH 11 de septiembre de 2026 Diario
IWX · iShares Trust 0,47% 91 310 SH 11 de septiembre de 2026 Diario
VTV · VANGUARD INDEX FUNDS 0,45% 6 058 224 SH 19 de agosto de 2026 Diario
QUVU · Hartford Funds Exchange-Traded Trust 0,44% 4 091 NS 31 de julio de 2026 N-PORT
EVUS · iShares Trust 0,43% 8 232 SH 11 de septiembre de 2026 Diario
FXH · First Trust Exchange-Traded AlphaDE… 0,43% 23 256 NS 31 de julio de 2026 N-PORT
IVE · iShares Trust 0,42% 1 046 214 SH 11 de septiembre de 2026 Diario
VOOV · VANGUARD ADMIRAL FUNDS 0,41% 145 011 SH 19 de agosto de 2026 Diario
IUSV · iShares Trust 0,40% 551 533 SH 11 de septiembre de 2026 Diario
ILCV · iShares Trust 0,38% 25 086 SH 11 de septiembre de 2026 Diario
SUSL · iShares Trust 0,37% 22 482 SH 11 de septiembre de 2026 Diario
CHRI · Global X Funds 0,37% 153 NS 31 de julio de 2026 N-PORT
DSI · iShares Trust 0,36% 97 358 SH 11 de septiembre de 2026 Diario
IUS · Invesco Exchange-Traded Self-Indexe… 0,36% 16 095 SH 5 de octubre de 2026 Diario
DFUV · Dimensional ETF Trust 0,35% 277 749 NS 31 de julio de 2026 N-PORT
IWD · iShares Trust 0,34% 1 404 243 SH 11 de septiembre de 2026 Diario
VONV · VANGUARD SCOTTSDALE FUNDS 0,34% 381 505 SH 19 de agosto de 2026 Diario
SUSA · iShares Trust 0,29% 58 103 SH 11 de septiembre de 2026 Diario
OEF · iShares Trust 0,27% 266 715 SH 11 de septiembre de 2026 Diario
PFIG · Invesco Exchange-Traded Fund Trust … 0,25% 346 000 5 de octubre de 2026 Diario
VFVA · VANGUARD WELLINGTON FUND 0,25% 11 236 SH 19 de agosto de 2026 Diario
DFLV · Dimensional ETF Trust 0,24% 84 826 NS 31 de julio de 2026 N-PORT
DGRO · iShares Trust 0,24% 521 760 SH 11 de septiembre de 2026 Diario
USCL · iShares Trust 0,24% 33 717 SH 11 de septiembre de 2026 Diario
TOPC · iShares Trust 0,23% 381 SH 11 de septiembre de 2026 Diario
MGC · VANGUARD WORLD FUND 0,23% 127 343 SH 19 de agosto de 2026 Diario
ACVF · ETF Opportunities Trust 0,23% 1 783 NS 31 de julio de 2026 N-PORT
QVML · Invesco Exchange-Traded Fund Trust … 0,23% 17 906 SH 5 de octubre de 2026 Diario
IWL · iShares Trust 0,22% 24 594 SH 11 de septiembre de 2026 Diario
PRF · Invesco Exchange-Traded Fund Trust 0,22% 102 567 SH 5 de octubre de 2026 Diario
SIZE · iShares Trust 0,22% 4 614 SH 11 de septiembre de 2026 Diario
XVV · iShares Trust 0,22% 7 252 SH 11 de septiembre de 2026 Diario
RSP · Invesco Exchange-Traded Fund Trust 0,21% 950 514 SH 5 de octubre de 2026 Diario
ESGV · VANGUARD WORLD FUND 0,21% 142 869 SH 19 de agosto de 2026 Diario
PBUS · Invesco Exchange-Traded Fund Trust … 0,21% 102 791 SH 5 de octubre de 2026 Diario
PBP · Invesco Exchange-Traded Fund Trust 0,21% 3 722 SH 5 de octubre de 2026 Diario
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,20% 4 805 NS 31 de julio de 2026 N-PORT
ILCB · iShares Trust 0,20% 12 530 SH 11 de septiembre de 2026 Diario
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,19% 88 851 NS 31 de julio de 2026 N-PORT
VOTE · TCW ETF Trust 0,19% 10 899 NS 31 de julio de 2026 N-PORT
EUSA · iShares, Inc. 0,19% 18 450 SH 11 de septiembre de 2026 Diario
IVV · iShares Trust 0,19% 7 939 826 SH 11 de septiembre de 2026 Diario
VOXP · Advisors Series Trust 0,19% 57 NS 31 de julio de 2026 N-PORT
XCLR · Global X Funds 0,19% 35 NS 31 de julio de 2026 N-PORT
PTLC · Pacer Funds Trust 0,19% 31 952 NS 31 de julio de 2026 N-PORT
XRMI · Global X Funds 0,19% 489 NS 31 de julio de 2026 N-PORT
XYLD · Global X Funds 0,19% 31 674 NS 31 de julio de 2026 N-PORT
XTR · Global X Funds 0,19% 47 NS 31 de julio de 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0,19% 16 363 510 SH 19 de agosto de 2026 Diario
VV · VANGUARD INDEX FUNDS 0,19% 743 939 SH 19 de agosto de 2026 Diario
TOV · EA Series Trust 0,19% 2 581 NS 31 de julio de 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,19% 53 257 NS 31 de julio de 2026 N-PORT
ADME · ETF Series Solutions 0,19% 2 836 NS 31 de julio de 2026 N-PORT
ACIO · ETF Series Solutions 0,19% 22 752 NS 31 de julio de 2026 N-PORT
XYLG · Global X Funds 0,19% 616 NS 31 de julio de 2026 N-PORT
IWB · iShares Trust 0,18% 437 462 SH 11 de septiembre de 2026 Diario
IYY · iShares Trust 0,18% 27 014 SH 11 de septiembre de 2026 Diario
PEVC · Pacer Funds Trust 0,18% 22 NS 31 de julio de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,18% 189 347 NS 31 de julio de 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,18% 2 377 NS 31 de julio de 2026 N-PORT
IWV · iShares Trust 0,17% 174 302 SH 11 de septiembre de 2026 Diario
QDPL · Pacer Funds Trust 0,17% 15 178 NS 31 de julio de 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,17% 5 511 000 5 de octubre de 2026 Diario
ITOT · iShares Trust 0,17% 820 097 SH 11 de septiembre de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,17% 20 226 391 SH 19 de agosto de 2026 Diario
VONE · VANGUARD SCOTTSDALE FUNDS 0,17% 104 620 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,17% 53 219 SH 19 de agosto de 2026 Diario
ESGU · iShares Trust 0,17% 151 590 SH 11 de septiembre de 2026 Diario
PHDG · Invesco Actively Managed Exchange-T… 0,17% 493 SH 5 de octubre de 2026 Diario
TILT · FlexShares Trust 0,16% 18 486 NS 31 de julio de 2026 N-PORT
TOK · iShares Trust 0,15% 1 797 SH 11 de septiembre de 2026 Diario
HCMT · Direxion Shares ETF Trust 0,15% 4 381 NS 31 de julio de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,15% 17 583 NS 31 de julio de 2026 N-PORT
CRBN · iShares Trust 0,15% 8 649 SH 11 de septiembre de 2026 Diario
OMFL · Invesco Exchange-Traded Self-Indexe… 0,14% 31 801 SH 5 de octubre de 2026 Diario
SPXL · Direxion Shares ETF Trust 0,14% 49 245 NS 31 de julio de 2026 N-PORT
URTH · iShares, Inc. 0,14% 56 946 SH 11 de septiembre de 2026 Diario
RWL · Invesco Exchange-Traded Fund Trust … 0,13% 61 158 SH 5 de octubre de 2026 Diario
DFAU · Dimensional ETF Trust 0,13% 83 138 NS 31 de julio de 2026 N-PORT
ACWI · iShares Trust 0,12% 201 808 SH 11 de septiembre de 2026 Diario
DCOR · Dimensional ETF Trust 0,12% 20 495 NS 31 de julio de 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 3 770 SH 5 de octubre de 2026 Diario
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,10% 523 769 SH 19 de agosto de 2026 Diario
FEX · First Trust Exchange-Traded AlphaDE… 0,09% 7 398 NS 31 de julio de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,08% 206 412 NS 31 de julio de 2026 N-PORT
FBCG · FIDELITY COVINGTON TRUST 0,07% 25 158 NS 31 de julio de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,05% 1 457 NS 31 de julio de 2026 N-PORT
DYNF · BlackRock ETF Trust 0,05% 104 339 SH 11 de septiembre de 2026 Diario
BLV · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
BSV · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
BND · VANGUARD BOND INDEX FUNDS · · 15 de julio de 2026 Diario
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 de julio de 2026 Diario
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 de julio de 2026 Diario
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 de julio de 2026 Diario
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 de julio de 2026 Diario
BNDX · VANGUARD CHARLOTTE FUNDS · · 15 de julio de 2026 Diario
VCEB · VANGUARD WORLD FUND · · 30 de julio de 2026 Diario

DHR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 32 analistas COMPRA
Objetivo mediano $233.00 +8,1%
12 37,5% Compra fuerte
15 46,9% Compra
5 15,6% Mantener
0 0,0% Venta
0 0,0% Venta fuerte

Precio objetivo a 12 meses

22 analistas · 2026-10-02

Objetivo medio $234.73 +8,9%

Ahora Precio Actual $215.61
Mín$200.00 Media$234.73 Máx$310.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
DHR $161.82B 45.3 2.9% 14.7% 7.1% 59.1%
TMO $257.86B 32.7 3.9% 15.0% 13.0% ·
A $41.43B 32.0 6.7% 18.8% 20.6% ·
WAT $22.62B 35.3 7.0% 20.3% 27.2% ·
IQV $38.23B 28.8 5.9% 8.3% 21.6% ·
ILMN $20.65B 24.8 -0.66% 19.6% 34.1% 66.1%
MTD $28.38B 33.2 4.0% 21.6% -615.5% 59.4%
WST $19.81B 40.5 6.2% 16.1% 16.2% 35.9%
RVTY $10.86B 46.7 3.7% 8.5% 3.3% ·
MEDP $15.93B 36.8 20.0% 17.8% 142.9% ·
CRL $10.02B -70.0 -0.85% -3.6% -4.4% ·

Últimas noticias Noticias recientes que mencionan a esta empresa

23

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Jul 21, 2026